PREVALANCE OF SARCOPENIA IN CARCINOMA ESOPHAGUS: A HOSPITAL BASED PROSPECTIVE OBSERVATIONAL STUDY
Ishan Barotra*, Ashish Katoch, Puneet Mahajan and Rashpal Singh Thakur
ABSTRACT
Background: Esophageal cancer remains a disease with poor survival and many complications. The aim of this study was to determine the prevalence of sarcopenia in esophageal malignancy patients using computed tomography. Methods: A hospital based prospective observational study was conducted in the Department of General Surgery of a tertiary care hospital in Shimla, Himachal Pradesh. All patients who reported to Department of Surgery during the study period of 1st September 2021 to 30th September 2022 with diagnosis of esophageal cancer were considered for the study. Results: Eighteen patients were included in the study. Prevalence of sarcopenia was 44.44% (8 patients) based on EWGSOP2 (The European Working Group on Sarcopenia in Older People 2) recommendations. Patients had a mean age of 60.43± 14.16 years. Sarcopenia was detected in 8(44.44%) patients based on EWGSOP2 (The European Working Group on Sarcopenia in Older People 2) recommendations. The mean age was 65.37 years in the sarcopenic group (SG) and 55.5 years in the non-sarcopenic group (NSG).The mean SMI (Skeletal Muscle Index) was 42.23±7.10 cm²/m² and 47.14±6.24 cm²/m² in the SG and NSG, respectively. The mean body mass index (BMI) was lower in the sarcopenic group than in the nonsarcopenic group (19.11 ± 1.99 vs. 19.83± 2.13s kg/m2). Conclusions: Prevalence of sarcopenia was 44.44% (8 patients) based on EWGSOP2 (The European Working Group on Sarcopenia in Older People 2) recommendations.
Keywords: Sarcopenia _ Prevalance_ esophageal malignancy _Sub Himalayan Region.
[Full Text Article]
[Download Certificate]